Andrew Huberman· PhD
Well, often it's in combinations, and I would say 80%.
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Well, often it's in combinations, and I would say 80%.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
but these days I really find myself only fiddling with about three statins truthfully and this excludes patients who show up on one already that they inherit so atorvastatin or something like that but in terms of a naive patient I would say it's really mostly two it's really rezuvastatin and then patavastatin with occasional pravastatin